Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CATEQUENTINIB vs CEFIDEROCOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CATEQUENTINIB vs CEFIDEROCOL: Safety Overview

Metric CATEQUENTINIB CEFIDEROCOL
Total FAERS Reports 324 649
Deaths Reported 44 359
Death Rate 13.6% 55.3%
Hospitalizations 115 134
Average Patient Age 57.2 yrs 57.0 yrs
% Female Patients 38.7% 37.9%
FDA Approval Date N/A Nov 14, 2019
Manufacturer N/A Shionogi Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription